• $8.5M
    Market Cap
  • -74.14%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.8M
-66.05%
-5.4M
-10.59%
-6.0M
+27.12%
-4.8M
+134.18%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
8.1M
-42.62%
14.1M
-3.26%
14.6M
+20.55%
12.1M
-5.63%
Operating Profit
-8.1M
-42.62%
-14.1M
-3.26%
-14.6M
+20.55%
-12.1M
-5.14%
Interest Income
125,445
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
125,445
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-8.1M
-42.62%
-14.1M
-3.26%
-14.6M
+20.55%
-12.1M
-5.14%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-8.0M
-43.51%
-14.1M
-3.26%
-14.6M
+20.55%
-12.1M
-5.14%
Net Income from Continuing Operations Applicable to Common
-8.0M
-43.51%
-14.1M
-3.26%
-14.6M
+20.55%
-12.1M
-5.14%
Basic EPS and Net Income
-5.32
+511.49%
-0.87
-24.35%
-1.15
+2.68%
-1.12
-24.83%
Diluted EPS and Net Income
-5.32
+511.49%
-0.87
-24.35%
-1.15
+2.68%
-1.12
-24.83%
Basic Weighted Average Shares
1.5M
-90.73%
16.2M
+27.56%
12.7M
+17.15%
10.8M
+26.72%
Diluted Weighted Average Shares
1.5M
-90.73%
16.2M
+27.56%
12.7M
+17.15%
10.8M
+26.72%
Balance Sheet
Cash and Cash Equivalents
7.6M
+103.85%
3.7M
-50.41%
7.5M
-17.97%
9.1M
-29.69%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
7.6M
+103.85%
3.7M
-50.41%
7.5M
-17.97%
9.1M
-29.69%
Total Current Assets
7.6M
+100.72%
3.8M
-49.78%
7.6M
-19.16%
9.4M
-29.25%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
7.7M
+99.32%
3.9M
-49.96%
7.7M
-17.78%
9.4M
-29.25%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
2.4M
-25.35%
3.2M
+6.59%
3.0M
+47.57%
2.1M
+144.30%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
2.4M
-25.35%
3.2M
+6.59%
3.0M
+47.57%
2.1M
+144.30%
Retained Earnings
-75.3M
+11.83%
-67.3M
+26.50%
-53.2M
+37.73%
-38.6M
+45.55%
Total Stockholders Equity
5.3M
+756.51%
615,121
-86.82%
4.7M
-36.20%
7.3M
-41.06%
Total Shares Outstanding
2.3M
-86.21%
17.0M
+17.71%
14.5M
+24.43%
11.6M
+13.82%
Cash Flow
Cash from Operating Activities
-6.8M
-34.63%
-10.4M
+5.94%
-9.8M
+29.95%
-7.5M
+50.43%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.6M
+60.78%
6.6M
-18.96%
8.2M
+120.92%
3.7M
-75.03%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-137.98%
-43.42%
-243.85%
+42.90%
-170.64%
+59.67%
-106.87%
N/A
Return on Equity
-270.80%
-49.29%
-534.03%
+119.46%
-243.33%
+98.46%
-122.61%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.16
+168.87%
1.17
-52.88%
2.49
-45.22%
4.55
N/A
Cash Ratio
3.12
+173.06%
1.14
-53.47%
2.46
-44.42%
4.42
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow